Virtual JPM: The Industry's Big Annual Party Will Take Place Without The Party
The industry's big annual meeting will take place virtually because of COVID-19
Executive Summary
The J.P. Morgan Healthcare conference – where the biopharma industry usually kicks off the year – will be held virtually in 2021, because of COVID-19.
You may also be interested in...
A Muted J.P. Morgan, But The Focus Is Execution – And That's Good News
A lack of deal news at the J.P. Morgan Healthcare Conference didn't excite investors, but industry is confidently executing on focused strategies as it welcomes a new decade. The persistent overhang is US drug pricing and political uncertainty.
With Winrevair Approved, Merck Has A Chance To Execute On CV Strategy
The activin signaling inhibitor sotatercept was approved by the US FDA for pulmonary arterial hypertension.
CinFina Pushes Early Work In Obesity In Hopes Of A Deal
Emerging Company Profile: CinFina is advancing two novel mechanisms of action in obesity as monotherapies and in combination with GLP-1s.